SpliceBio

Barcelona, Spain · Founded 2012 · Privately Held (backing)

Operator of a biotechnology company intended to develop genetic medicines through protein-splicing gene therapy. SpliceBio is based in Barcelona, Spain and was founded in 2012. Its last reported valuation was $84.5 million in Feb 2022. It has raised $198 million.

Last reported valuation
$84.5M
Oct 2026
Priced at
—
Total raised
$198.0M
Last round
—

Who backs SpliceBio?

11 investors
InvestorType
New Enterprise AssociatesVenture capital
EQT Life SciencesVenture capital
Gilde HealthcarePE / buyout
Novartis Venture FundOther
Caixa Capital RiscOther
Cystic Fibrosis Foundation—
Princeton University—
Roche Venture Fund—
Sanofi Ventures—
UCB Ventures—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

SpliceBio investors

11 investors are on record for SpliceBio, including New Enterprise Associates, EQT Life Sciences, Gilde Healthcare and Novartis Venture Fund.

Free account
More of SpliceBio with a free account
  • ·The complete investor list: 11 names
  • ·Watch SpliceBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like SpliceBio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View